Evaluating prognostic biomarkers for survival outcomes subject to informative censoring
Statistical Methods in Medical Research · 2024
DOI: 10.1177/09622802241259170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2024. Verfasst von Wei Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Management, Harbin Institute of Technology, Harbin, China. Hauptthemen laut MEDLINE: Biomarkers, Breast Neoplasms, ROC Curve. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Prognostic biomarkers for survival outcomes are widely used in clinical research and practice. Such biomarkers are often evaluated using a C-index as well as quantities based on time-dependent receiver operating characteristic curves. Existing methods for their evaluation generally assume that censoring is uninformative in the sense that the censoring time is independent of the failure time with or without conditioning on the biomarker under evaluation. With focus on the C-index and the area under a particular receiver operating characteristic curve, we describe and compare three estimation methods that account for informative censoring based on observed baseline covariates. Two of them are straightforward extensions of existing plug-in and inverse probability weighting methods for uninformative censoring. By appealing to semiparametric theory, we also develop a doubly robust, locally efficient method that is more robust than the plug-in and inverse probability weighting methods and typically more efficient than the inverse probability weighting method. The methods are evaluated and compared in a simulation study, and applied to real data from studies of breast cancer and heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Management, Harbin Institute of Technology, Harbin, China.
- Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Biostatistics Innovation Group, Gilead Sciences Inc, Foster City, CA, USA.
ORCID-Profile: Wei Liu, Zhiwei Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, W., Liu, D., & Zhang, Z. (2024). Evaluating prognostic biomarkers for survival outcomes subject to informative censoring. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802241259170
Vancouver
Liu W, Liu D, Zhang Z. Evaluating prognostic biomarkers for survival outcomes subject to informative censoring. Statistical Methods in Medical Research. 2024. doi:10.1177/09622802241259170
BibTeX
@article{Liu2024,
author = {Liu, Wei and Liu, Danping and Zhang, Zhiwei},
title = {Evaluating prognostic biomarkers for survival outcomes subject to informative censoring},
journal = {Statistical Methods in Medical Research},
year = {2024},
doi = {10.1177/09622802241259170}
}
EUVIMED